Ignite Creation Date:
2025-12-24 @ 10:02 PM
Ignite Modification Date:
2026-01-01 @ 3:19 AM
Study NCT ID:
NCT05560932
Status:
COMPLETED
Last Update Posted:
2025-07-04
First Post:
2022-09-26
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
HIV and Alcohol Research Center Focused on Polypharmacy (HARP) Pilot 1
Sponsor:
Yale University
Organization:
Study Overview
Official Title:
HIV and Alcohol Research Center Focused on Polypharmacy (HARP) Pilot 1
Status:
COMPLETED
Status Verified Date:
2025-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This pilot intervention will consist of a brief intervention for patients with HIV who take 5 or more medications and currently (within the past month) consume alcohol. The focus of this pilot will be on bothersome symptoms and the impact of alcohol use and medications on these symptoms. The rationale is that any alcohol use may interact with medications in serious ways leading to adverse outcomes, including bothersome symptoms.
Detailed Description:
Additional outcomes were added at results entry.
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
Secondary ID Infos
| Secondary ID | Type | Domain | Link | View |
|---|---|---|---|---|
| P01AA029545-03 | NIH | None | https://reporter.nih.gov/quic… | View |
| P01 AA029545-03 sub 9238 | OTHER_GRANT | Sub Award P01 AA029545-03 | View |